These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35643319)

  • 1. Type II BMP and activin receptors BMPR2 and ACVR2A share a conserved mode of growth factor recognition.
    Chu KY; Malik A; Thamilselvan V; Martinez-Hackert E
    J Biol Chem; 2022 Jul; 298(7):102076. PubMed ID: 35643319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
    Olsen OE; Sankar M; Elsaadi S; Hella H; Buene G; Darvekar SR; Misund K; Katagiri T; Knaus P; Holien T
    J Cell Sci; 2018 Jun; 131(11):. PubMed ID: 29739878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.
    Olsen OE; Wader KF; Hella H; Mylin AK; Turesson I; Nesthus I; Waage A; Sundan A; Holien T
    Cell Commun Signal; 2015 Jun; 13():27. PubMed ID: 26047946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding.
    Lowery JW; Amich JM; Andonian A; Rosen V
    Cell Mol Life Sci; 2014 Aug; 71(16):3165-72. PubMed ID: 24337809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of BMPR2 leads to high bone mass due to increased osteoblast activity.
    Lowery JW; Intini G; Gamer L; Lotinun S; Salazar VS; Ote S; Cox K; Baron R; Rosen V
    J Cell Sci; 2015 Apr; 128(7):1308-15. PubMed ID: 25663702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.
    Aykul S; Martinez-Hackert E
    J Biol Chem; 2016 May; 291(20):10792-804. PubMed ID: 26961869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells.
    Rejon CA; Hancock MA; Li YN; Thompson TB; Hébert TE; Bernard DJ
    Cell Signal; 2013 Dec; 25(12):2717-26. PubMed ID: 24018044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine FSH Production Depends on the Activin Type II Receptors ACVR2A and ACVR2B.
    Schang G; Ongaro L; Schultz H; Wang Y; Zhou X; Brûlé E; Boehm U; Lee SJ; Bernard DJ
    Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32270195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
    Yu PB; Beppu H; Kawai N; Li E; Bloch KD
    J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
    Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
    BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.
    Goh BC; Singhal V; Herrera AJ; Tomlinson RE; Kim S; Faugere MC; Germain-Lee EL; Clemens TL; Lee SJ; DiGirolamo DJ
    J Biol Chem; 2017 Aug; 292(33):13809-13822. PubMed ID: 28659341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways.
    Szilágyi SS; Amsalem-Zafran AR; Shapira KE; Ehrlich M; Henis YI
    BMC Biol; 2022 Feb; 20(1):50. PubMed ID: 35177083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance linked to functional defects in bone morphogenetic protein type 2 receptor, BMPR2.
    Kim MJ; Park SY; Chang HR; Jung EY; Munkhjargal A; Lim JS; Lee MS; Kim Y
    BMB Rep; 2017 Jun; 50(6):308-317. PubMed ID: 28391780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
    Upton PD; Davies RJ; Trembath RC; Morrell NW
    J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function.
    Leyton PA; Beppu H; Pappas A; Martyn TM; Derwall M; Baron DM; Galdos R; Bloch DB; Bloch KD
    PLoS One; 2013; 8(10):e76947. PubMed ID: 24116187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
    Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
    Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Modulating BMP9, BMPR2, and AQP1 on BMP Signaling in Human Pulmonary Microvascular Endothelial Cells.
    Lotsios NS; Keskinidou C; Dimopoulou I; Kotanidou A; Langleben D; Orfanos SE; Vassiliou AG
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.
    Fujiwara M; Yagi H; Matsuoka R; Akimoto K; Furutani M; Imamura S; Uehara R; Nakayama T; Takao A; Nakazawa M; Saji T
    Circ J; 2008 Jan; 72(1):127-33. PubMed ID: 18159113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
    Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.